ChemicalsCompany
Actylis M&A Summary
Actylis has acquired 12 companies of its own, including 8 in the last 5 years. It has also divested 1 asset.
Actylis’ largest acquisition to date was in 2010, when it acquired Rising Pharmaceuticals for $80M. It’s largest disclosed sale occurred in 2019, when it sold Rising Pharmaceuticals to H.I.G. Private Equity for $15M. Actylis has acquired in 4 different US states, and 5 countries. The Company’s most targeted sectors include chemicals (50%) and life science (25%).
Actylis Ownership
Who owns Actylis?
Actylis is owned by New Mountain Capital. It was acquired on April 16, 2019.
Is Actylis PE-backed?
Yes. Actylis is owned by private equity investor New Mountain Capital.
Actylis Business Overview
Where is Actylis headquartered?
Actylis is headquartered in Port Washington, New York.
What is Actylis’ revenue?
Actylis disclosed revenue of 711M USD for 2018 and 638M USD for 2017.
What sector is Actylis in?
Actylis is a chemicals company.
When was Actylis founded?
Actylis was founded in 1947.
M&A Summary
-
M&A Total Activity13
- M&A Buy Activity12
- M&A Sell Activity1
- Total Sectors Invested 4
- Total Countries Invested 5
- M&A Buy/Sell Connections 4
- M&A Advisors 5
Unlimited Searches
